Cite
Discovery of Novel Benzo[4,5]imidazo[1,2‑a]pyrazin-1-amine-3-amide-one Derivatives as Anticancer Human A2A Adenosine Receptor Antagonists.
MLA
Liu, Shuhao, et al. “Discovery of Novel Benzo[4,5]Imidazo[1,2‑a]Pyrazin-1-Amine-3-Amide-One Derivatives as Anticancer Human A2A Adenosine Receptor Antagonists.” Journal of Medicinal Chemistry, vol. 65, no. 13, July 2022, pp. 8933–47. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.2c00101.
APA
Liu, S., Ding, W., Huang, W., Zhang, Z., Guo, Y., Zhang, Q., Wu, L., Li, Y., Qin, R., Li, J., Shi, T., Zhang, X., Lei, J., & Hu, W. (2022). Discovery of Novel Benzo[4,5]imidazo[1,2‑a]pyrazin-1-amine-3-amide-one Derivatives as Anticancer Human A2A Adenosine Receptor Antagonists. Journal of Medicinal Chemistry, 65(13), 8933–8947. https://doi.org/10.1021/acs.jmedchem.2c00101
Chicago
Liu, Shuhao, Wen Ding, Weifeng Huang, Zhijing Zhang, Yinfeng Guo, Qiyi Zhang, Linna Wu, et al. 2022. “Discovery of Novel Benzo[4,5]Imidazo[1,2‑a]Pyrazin-1-Amine-3-Amide-One Derivatives as Anticancer Human A2A Adenosine Receptor Antagonists.” Journal of Medicinal Chemistry 65 (13): 8933–47. doi:10.1021/acs.jmedchem.2c00101.